Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Raderer

Showing results (1-10 of 264) with videos related to

Pageof 27
Sort By:
Hematological Oncology|June 8, 2017
The multiple faces of marginal zone lymphomasMarkus Raderer
Therapeutic Advances in Medical Oncology|October 8, 2021
What you always wanted to know about gastric MALT-lymphoma: a focus on recent developmentsMarkus Raderer, Barbara Kiesewetter
Hematological Oncology|May 30, 2020
Immunomodulatory treatment for mucosa-associated lymphoid tissue lymphoma (MALT lymphoma)Barbara Kiesewetter, Markus Raderer
Expert Review of Hematology|March 25, 2021
How can we assess and measure prognosis for MALT lymphoma? A review of current findings and strategiesBarbara Kiesewetter, Markus Raderer
American Journal of Hematology|November 30, 2005
Monoclonal gammmopathy (MG) in extranodal marginal zone lymphoma (ENMZL)Stefan Wohrer, Markus Raderer
Memo|January 1, 2019
My burning issues in neuroendocrine tumours (NET)Barbara Kiesewetter, Markus Raderer
The New England Journal of Medicine|May 17, 2013
Ondansetron for diarrhea associated with neuroendocrine tumorsBarbara Kiesewetter, Markus Raderer
Leukemia & Lymphoma|August 15, 2014
Underlying autoimmune diseases are not aggravated during treatment with lenalidomide in patients with mucosa-associated lymphoid tissue lymphomaBarbara Kiesewetter, Markus Raderer
Blood|June 18, 2013
Antibiotic therapy in nongastrointestinal MALT lymphoma: a review of the literatureBarbara Kiesewetter, Markus Raderer
ESMO Open|August 21, 2020
How I treat neuroendocrine tumoursBarbara Kiesewetter, Markus Raderer
Pageof 27

Showing results (1-10 of 264) with videos related to

Sort By:
Pageof 27
Hematological Oncology|June 8, 2017
The multiple faces of marginal zone lymphomasMarkus Raderer
Therapeutic Advances in Medical Oncology|October 8, 2021
What you always wanted to know about gastric MALT-lymphoma: a focus on recent developmentsMarkus Raderer, Barbara Kiesewetter
Hematological Oncology|May 30, 2020
Immunomodulatory treatment for mucosa-associated lymphoid tissue lymphoma (MALT lymphoma)Barbara Kiesewetter, Markus Raderer
Expert Review of Hematology|March 25, 2021
How can we assess and measure prognosis for MALT lymphoma? A review of current findings and strategiesBarbara Kiesewetter, Markus Raderer
American Journal of Hematology|November 30, 2005
Monoclonal gammmopathy (MG) in extranodal marginal zone lymphoma (ENMZL)Stefan Wohrer, Markus Raderer
Memo|January 1, 2019
My burning issues in neuroendocrine tumours (NET)Barbara Kiesewetter, Markus Raderer
The New England Journal of Medicine|May 17, 2013
Ondansetron for diarrhea associated with neuroendocrine tumorsBarbara Kiesewetter, Markus Raderer
Leukemia & Lymphoma|August 15, 2014
Underlying autoimmune diseases are not aggravated during treatment with lenalidomide in patients with mucosa-associated lymphoid tissue lymphomaBarbara Kiesewetter, Markus Raderer
Blood|June 18, 2013
Antibiotic therapy in nongastrointestinal MALT lymphoma: a review of the literatureBarbara Kiesewetter, Markus Raderer
ESMO Open|August 21, 2020
How I treat neuroendocrine tumoursBarbara Kiesewetter, Markus Raderer
Pageof 27